 Michael Cain
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organ Preservation | 9 | 2026 | 130 | 1.860 |
Why?
| | Perfusion | 10 | 2025 | 250 | 1.650 |
Why?
| | Tissue and Organ Procurement | 9 | 2026 | 346 | 1.650 |
Why?
| | Tissue Donors | 8 | 2026 | 424 | 1.570 |
Why?
| | Extracorporeal Membrane Oxygenation | 5 | 2026 | 383 | 1.470 |
Why?
| | Ventricular Dysfunction, Right | 4 | 2022 | 248 | 1.410 |
Why?
| | Lung Transplantation | 3 | 2025 | 338 | 0.920 |
Why?
| | Sternotomy | 2 | 2022 | 23 | 0.890 |
Why?
| | Heart Transplantation | 7 | 2026 | 736 | 0.880 |
Why?
| | Cerebrovascular Circulation | 2 | 2025 | 280 | 0.770 |
Why?
| | Coronary Artery Disease | 3 | 2026 | 741 | 0.710 |
Why?
| | Heart Arrest, Induced | 1 | 2021 | 34 | 0.690 |
Why?
| | Pulmonary Embolism | 2 | 2021 | 244 | 0.690 |
Why?
| | Hypertension, Pulmonary | 4 | 2023 | 1980 | 0.680 |
Why?
| | Heart-Assist Devices | 4 | 2022 | 567 | 0.680 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2021 | 24 | 0.670 |
Why?
| | Vascular Stiffness | 1 | 2023 | 486 | 0.560 |
Why?
| | Hamstring Muscles | 1 | 2017 | 22 | 0.530 |
Why?
| | Brain Death | 3 | 2026 | 60 | 0.500 |
Why?
| | Tendon Injuries | 1 | 2017 | 73 | 0.500 |
Why?
| | Heart Failure | 4 | 2025 | 2323 | 0.420 |
Why?
| | Primary Graft Dysfunction | 2 | 2025 | 35 | 0.420 |
Why?
| | Transposition of Great Vessels | 1 | 2014 | 41 | 0.400 |
Why?
| | Retrospective Studies | 13 | 2026 | 17066 | 0.350 |
Why?
| | Coronary Vessels | 2 | 2026 | 251 | 0.340 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2022 | 192 | 0.330 |
Why?
| | Endarterectomy | 2 | 2021 | 5 | 0.330 |
Why?
| | Treatment Outcome | 9 | 2025 | 11679 | 0.290 |
Why?
| | Coronary Artery Bypass | 2 | 2022 | 268 | 0.280 |
Why?
| | Humans | 35 | 2026 | 144759 | 0.280 |
Why?
| | Organ Transplantation | 3 | 2026 | 247 | 0.270 |
Why?
| | Cardiac Surgical Procedures | 3 | 2026 | 609 | 0.250 |
Why?
| | Waiting Lists | 2 | 2025 | 263 | 0.250 |
Why?
| | Registries | 2 | 2026 | 2385 | 0.240 |
Why?
| | Graft Survival | 2 | 2026 | 526 | 0.240 |
Why?
| | Failure to Rescue, Health Care | 1 | 2026 | 7 | 0.240 |
Why?
| | Blood Group Incompatibility | 1 | 2025 | 20 | 0.230 |
Why?
| | Stromal Cells | 1 | 2026 | 124 | 0.230 |
Why?
| | Consensus | 2 | 2024 | 488 | 0.230 |
Why?
| | ABO Blood-Group System | 1 | 2025 | 57 | 0.230 |
Why?
| | Male | 20 | 2026 | 72315 | 0.230 |
Why?
| | Intracranial Pressure | 1 | 2025 | 65 | 0.220 |
Why?
| | Pulmonary Artery | 2 | 2023 | 1134 | 0.220 |
Why?
| | Chronic Disease | 3 | 2021 | 1813 | 0.220 |
Why?
| | Death | 1 | 2025 | 130 | 0.220 |
Why?
| | Cell Communication | 1 | 2026 | 324 | 0.210 |
Why?
| | Morbidity | 2 | 2022 | 323 | 0.200 |
Why?
| | Biofilms | 3 | 2011 | 278 | 0.200 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 47 | 0.200 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 73 | 0.200 |
Why?
| | Transplant Recipients | 1 | 2025 | 180 | 0.200 |
Why?
| | Hospital Mortality | 2 | 2021 | 1030 | 0.190 |
Why?
| | Middle Aged | 11 | 2025 | 35875 | 0.190 |
Why?
| | Single-Cell Analysis | 1 | 2026 | 358 | 0.190 |
Why?
| | Fellowships and Scholarships | 1 | 2026 | 357 | 0.180 |
Why?
| | Antifungal Agents | 3 | 2011 | 149 | 0.170 |
Why?
| | Critical Care | 2 | 2021 | 695 | 0.170 |
Why?
| | Intensive Care Units | 2 | 2021 | 916 | 0.170 |
Why?
| | Drug Resistance, Fungal | 2 | 2011 | 7 | 0.170 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 297 | 0.170 |
Why?
| | Female | 15 | 2026 | 78271 | 0.170 |
Why?
| | Candida | 2 | 2011 | 44 | 0.160 |
Why?
| | Dancing | 1 | 2020 | 19 | 0.160 |
Why?
| | Diagnostic Imaging | 2 | 2013 | 338 | 0.160 |
Why?
| | Cannula | 1 | 2020 | 27 | 0.160 |
Why?
| | Fractures, Stress | 1 | 2020 | 31 | 0.160 |
Why?
| | Cardiac Catheterization | 1 | 2023 | 560 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 3 | 2023 | 3863 | 0.150 |
Why?
| | Mammary Arteries | 1 | 2019 | 8 | 0.150 |
Why?
| | Transcriptome | 1 | 2026 | 1045 | 0.150 |
Why?
| | Adult | 9 | 2025 | 40449 | 0.150 |
Why?
| | Blood Pressure | 1 | 2025 | 1769 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2026 | 2919 | 0.140 |
Why?
| | Macrophages | 1 | 2026 | 1511 | 0.140 |
Why?
| | Ischium | 1 | 2017 | 6 | 0.140 |
Why?
| | Aneurysm | 1 | 2018 | 37 | 0.140 |
Why?
| | Predictive Value of Tests | 1 | 2023 | 2115 | 0.140 |
Why?
| | Liver Transplantation | 1 | 2025 | 823 | 0.140 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1266 | 0.130 |
Why?
| | Suture Anchors | 1 | 2017 | 35 | 0.130 |
Why?
| | Rupture | 1 | 2017 | 91 | 0.130 |
Why?
| | Quality Improvement | 1 | 2026 | 1289 | 0.130 |
Why?
| | United States | 5 | 2026 | 15966 | 0.130 |
Why?
| | Vascular Surgical Procedures | 1 | 2020 | 339 | 0.130 |
Why?
| | Bone Density | 1 | 2020 | 482 | 0.120 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 139 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2021 | 708 | 0.120 |
Why?
| | Hemodynamics | 1 | 2021 | 1121 | 0.120 |
Why?
| | Perioperative Care | 1 | 2018 | 231 | 0.110 |
Why?
| | Catheters | 2 | 2013 | 75 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2925 | 0.110 |
Why?
| | Orthopedic Procedures | 1 | 2017 | 243 | 0.110 |
Why?
| | Aged | 4 | 2025 | 25913 | 0.110 |
Why?
| | Acute Disease | 1 | 2017 | 1030 | 0.110 |
Why?
| | Electronic Health Records | 2 | 2013 | 1173 | 0.110 |
Why?
| | Survival Rate | 3 | 2025 | 2089 | 0.110 |
Why?
| | Heart Diseases | 1 | 2017 | 349 | 0.100 |
Why?
| | Hospital Charges | 1 | 2014 | 46 | 0.100 |
Why?
| | Disease Management | 1 | 2018 | 645 | 0.100 |
Why?
| | Thrombosis | 1 | 2017 | 393 | 0.100 |
Why?
| | Technology Assessment, Biomedical | 1 | 2013 | 44 | 0.100 |
Why?
| | Radiology Department, Hospital | 1 | 2013 | 16 | 0.100 |
Why?
| | Radiology Information Systems | 1 | 2013 | 35 | 0.090 |
Why?
| | Software | 2 | 2013 | 690 | 0.090 |
Why?
| | Medical Errors | 1 | 2013 | 118 | 0.090 |
Why?
| | Cost of Illness | 1 | 2014 | 321 | 0.090 |
Why?
| | Workflow | 1 | 2013 | 184 | 0.090 |
Why?
| | Tetrazolium Salts | 1 | 2011 | 18 | 0.080 |
Why?
| | Candida albicans | 1 | 2011 | 61 | 0.080 |
Why?
| | Cell Wall | 1 | 2011 | 61 | 0.080 |
Why?
| | Radiology | 1 | 2013 | 174 | 0.080 |
Why?
| | Microbial Viability | 1 | 2011 | 90 | 0.080 |
Why?
| | Glucans | 1 | 2010 | 22 | 0.080 |
Why?
| | Decision Support Systems, Clinical | 1 | 2013 | 265 | 0.070 |
Why?
| | Prosthesis Implantation | 2 | 2020 | 153 | 0.070 |
Why?
| | Stroke | 1 | 2017 | 1256 | 0.070 |
Why?
| | Length of Stay | 1 | 2014 | 1337 | 0.070 |
Why?
| | Echocardiography, Transesophageal | 2 | 2018 | 133 | 0.060 |
Why?
| | Neointima | 1 | 2026 | 18 | 0.060 |
Why?
| | Allografts | 1 | 2026 | 150 | 0.060 |
Why?
| | Decision Making | 1 | 2013 | 975 | 0.060 |
Why?
| | Attitude of Health Personnel | 1 | 2013 | 1185 | 0.060 |
Why?
| | Brain | 1 | 2017 | 2933 | 0.060 |
Why?
| | Interferon Type I | 1 | 2026 | 145 | 0.060 |
Why?
| | Nitriles | 1 | 2026 | 205 | 0.050 |
Why?
| | Algorithms | 1 | 2013 | 1837 | 0.050 |
Why?
| | Abdomen | 1 | 2025 | 141 | 0.050 |
Why?
| | Young Adult | 2 | 2020 | 14105 | 0.050 |
Why?
| | Risk Factors | 2 | 2020 | 10779 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2026 | 266 | 0.050 |
Why?
| | Raffinose | 1 | 2023 | 29 | 0.050 |
Why?
| | United Kingdom | 1 | 2025 | 338 | 0.050 |
Why?
| | Allopurinol | 1 | 2023 | 69 | 0.050 |
Why?
| | Donor Selection | 1 | 2024 | 79 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2026 | 452 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2026 | 5408 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 219 | 0.050 |
Why?
| | Shock | 1 | 2024 | 108 | 0.050 |
Why?
| | Thoracic Surgical Procedures | 1 | 2024 | 94 | 0.050 |
Why?
| | Pyrimidines | 1 | 2026 | 532 | 0.050 |
Why?
| | Pyrazoles | 1 | 2026 | 509 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 6429 | 0.050 |
Why?
| | Adenosine | 1 | 2023 | 255 | 0.040 |
Why?
| | Glutathione | 1 | 2023 | 375 | 0.040 |
Why?
| | Graft Rejection | 1 | 2025 | 540 | 0.040 |
Why?
| | Shock, Cardiogenic | 1 | 2022 | 64 | 0.040 |
Why?
| | Fluconazole | 2 | 2011 | 23 | 0.040 |
Why?
| | Postoperative Period | 1 | 2022 | 354 | 0.040 |
Why?
| | Oligomenorrhea | 1 | 2020 | 8 | 0.040 |
Why?
| | Candidiasis | 2 | 2011 | 64 | 0.040 |
Why?
| | Surgeons | 1 | 2025 | 339 | 0.040 |
Why?
| | Body Fat Distribution | 1 | 2020 | 45 | 0.040 |
Why?
| | Cumulative Trauma Disorders | 1 | 2020 | 30 | 0.040 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2011 | 78 | 0.040 |
Why?
| | Fungal Proteins | 2 | 2011 | 145 | 0.040 |
Why?
| | Spinal Injuries | 1 | 2020 | 58 | 0.040 |
Why?
| | Internal Mammary-Coronary Artery Anastomosis | 1 | 2019 | 3 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 149 | 0.040 |
Why?
| | Absorptiometry, Photon | 1 | 2020 | 276 | 0.040 |
Why?
| | Colorado | 3 | 2013 | 4564 | 0.040 |
Why?
| | Spine | 1 | 2020 | 182 | 0.040 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2018 | 38 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1047 | 0.030 |
Why?
| | Pelvic Bones | 1 | 2020 | 135 | 0.030 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 162 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1720 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2730 | 0.030 |
Why?
| | Internship and Residency | 2 | 2026 | 1257 | 0.030 |
Why?
| | Prognosis | 1 | 2026 | 4282 | 0.030 |
Why?
| | Body Composition | 1 | 2020 | 706 | 0.030 |
Why?
| | Mice | 3 | 2026 | 18339 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2026 | 4557 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2026 | 5992 | 0.030 |
Why?
| | Reoperation | 1 | 2017 | 630 | 0.030 |
Why?
| | Sex Factors | 1 | 2020 | 2112 | 0.030 |
Why?
| | Time Factors | 1 | 2025 | 7173 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1694 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 760 | 0.020 |
Why?
| | Medical Order Entry Systems | 1 | 2013 | 40 | 0.020 |
Why?
| | Insulin | 1 | 2023 | 2507 | 0.020 |
Why?
| | Signal Transduction | 1 | 2026 | 5226 | 0.020 |
Why?
| | Appointments and Schedules | 1 | 2013 | 97 | 0.020 |
Why?
| | Rats | 2 | 2011 | 5597 | 0.020 |
Why?
| | Glucosyltransferases | 1 | 2011 | 4 | 0.020 |
Why?
| | beta-Glucans | 1 | 2011 | 16 | 0.020 |
Why?
| | Infant | 1 | 2025 | 10034 | 0.020 |
Why?
| | Animals | 3 | 2026 | 38058 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2011 | 116 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11787 | 0.020 |
Why?
| | Virulence | 1 | 2011 | 278 | 0.020 |
Why?
| | Protein Kinase C | 1 | 2011 | 252 | 0.020 |
Why?
| | Pediatrics | 1 | 1998 | 1114 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 370 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4271 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1985 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2027 | 0.010 |
Why?
| | Adolescent | 1 | 2023 | 22428 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3409 | 0.010 |
Why?
| | Hospital Information Systems | 1 | 1998 | 14 | 0.010 |
Why?
| | Computer Communication Networks | 1 | 1998 | 32 | 0.010 |
Why?
| | Information Storage and Retrieval | 1 | 1998 | 121 | 0.010 |
Why?
| | Clinical Clerkship | 1 | 1998 | 111 | 0.010 |
Why?
| | Program Evaluation | 1 | 1998 | 948 | 0.010 |
Why?
|
|
Cain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|